Beyond their oncological and reproductive applications, GnRH agonists have demonstrated therapeutic benefits in conditions associated with excessive estrogen production, like adenomyosis, uterine fibroids, and endometriosis. This evidence concerns the gene GNRH1 and uterine corpus leiomyoma.